Stock Events

Acadia Pharmaceuticals (ACAD) Q2 2017 Earnings

9MayConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-0.73
-0.66
-0.58
-0.51

Details

Expected EPS
-0.73
Actual EPS
-0.72
Surprise EPS
0.01
Surprise Percent
+1.37%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.72 per share for Q2 2017.

0 Comments

Share your thoughts